chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per patient she was in the third floor in the dentist office and decided to come to second floor and report it to the nurse. Per patient she has body ache, feels very cold, left arm is very sore, and pressure in the chest rated it at 6/10. Vital Signs Temperature 98.0, Pulse 97, Respiration 20, Blood Pressure 130/89, Oxygen saturation 97%. Patient is alert x4 and verbally responsive. No shortness of breath noted. No complain of nausea, vomiting, diarrhea. Reported to Dr, and to let patient know it is okay for patient to wait as a walk in to be seen by a provider in the afternoon session or go home and monitor, give ER precautions, and okay to take Tylenol. Per patient, decline to wait for the afternoon session as she had other obligations/appointments to attend this afternoon already. I gave patient paperwork information about Moderna vaccine and  VAERS paperwork.  ER precautions strongly advise the patient.
10hrs p/vax pt c/o dull pain in rt arm radiate to back & up into head; rt arm painful to move & touch, swollen, red rash around site; 5x8cm macular rash around site, warm; h/a, nausea, fever, achiness, dizziness; 27NOV91 PM to ER; admitted;
This spontaneous report as received from a physician who is a father of the patient via a company representative and refers to a 12-year-old male patient. The patient's concurrent conditions and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 (dosage, lot # and expiration date were not reported) intramuscularly for prophylaxis. After receiving the vaccine the patient fainted. The outcome of the event was not reported. The relatedness between vaccination with GARDASIL 9 and the event was not reported.
30 days after vaccine she burning and bad pain in the bones of her left thigh. She didn't have any strength to stand or walk. And since then she has this same feeling every 30 days. It last while then goes away.
My son got the MMR vaccine and 5 other vaccines then had eye spasms and the doctor lied and sead he was looking for something on the ceiling!? He was having a reaction to the vaccines  then lost waght had high fever.
Dose 1- Went from having zero sense of smell, to having very distorted sense of smell.  Constant bad odors such as spoiled milk, rotting meat.  The smells were phantom, and seemed to come from nowhere.  Still occurring   Dose 2:  Started having distorted taste.  Most foods and drinks taste putrid, spoiled and rotten.  Still occurring
complained of CP and SOB. Went to Hospital and had mild elevation in troponin. Had echo that was normal. Cardiac MRI suggestive of myopericarditis.
Last evening felt mild dizzy spells, tachycardia and was hot trying to sleep for a couple hours. Today feel ok minus a dizzy spell here and there. Nothing like I am going to fall over or pass out more just a passing weird dizzy feeling.
01/07/22 presents to EC ED for "right-sided weakness". PMHx of "Hypertension, hepatitis C, CKD"
I had flu like symptoms. I had a headache, chills, and a fever. I stayed in bed for about 24 hours, and my symptoms lasted for about 24 hours. Then I started feeling better.
From initial information received on 06/15/2005 from another manufacturer regarding an adverse event occurring in the USA, it was reported that on an unspecified date after 08/21/2002 and before 10/2002, received a dose of diphtheria, tetanus and acellular pertussis vaccine as the first dose in the diphtheria, tetanus and acellular pertussis vaccination series. On an unspecified date in October 2002, the patient received a dose of diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed, as the second dose in the diphtheria, tetanus and acellular pertussis vaccination series. On an unspecified date in February 2002, the patient received a dose of Infanrix as the third dose in the diphtheria, tetanus and acellular pertussis vaccination series. Per the reporter, this was longer than the recommended interval of four to eight weeks between the second and third doses of Infanrix. On an unspecified date in February 2003, the patient received a doses of Infanrix as the fourth dose in the diphtheria, tetanus and acellular pertussis vaccination series. On 09/22/2003, the patient received the first dose of Engerix-B. On 03/01/2004, the patient received the second dose of Engerix B. Per the reporter, this was longer than the recommended interval of one month between the first and second doses of Engerix B. On unspecified date before 05/26/2005, the patient also received injections of 7 valen pneumococcal conjugate vaccine and Haemophilus influenzae. On an unspecified date in 2005 on or before 05/26/2005, the subject was diagnosed with autism. The outcome of the autism was not reported.
The pt reported to boot camp on 3/15/10 and was healthy at the time. He received multiple vaccinations on 3/16/10. The pt reported on medical on 3/29/10 with complaints of 4d hx of numbness and tingling in his great toes, back of his legs, finger tips, lower back and gluteus medias. The pt followed-up in medical on 3/30/10 with additional complaints of weakness in his thighs and balance problems. At this time he also mentioned that he had a 5 day history of a productive cough (white mucous; no other symptoms; many other platoon members with cough also). The pt was seen by a civilian neurologist who documented "mild leg weakness in association with absent deep tendon reflexes." See EMG and MRI results below. The pt was admitted to hospital with the diagnosis of lumbarsacral radiculopathy, carpal tunnel syndrome, GUYON's canal syndrome and tarsal tunnel syndrome. The pt was discharged on 3/31/10. On 4/3/10 the pt complained of facial numbness (left > right), no difficulty swallowing or breathing. An LP was performed in the ER and the pt was admitted to hospital with the diagnosis of GBS. He subsequently developed bilateral facial paresis in a peripheral nerve distribution. He did experience very mild dysphagia for thin liquids and was briefly placed on a thickened liquid diet. He received a 3 day course of IVIG at a dose of .8gm/kg/day. The pt did experience a few episodes of orthostasis with nausea, emesis and headache which were attributed to autonomic instability from the GBS. This has resolved. As of 4/16/10 his dysphagia has resolved and his bifacial paresis, ataxia and strength have improved significantly. Remaining deficits included: mild left peripheral facial weakness with diminished strength of lid closure of the left, absent deep tendon reflexes (except for bilateral biceps brachii).
Information has been received from a licensed practical nurse concerning a 66 year old female patient with hypercholesterolaemia, "reflux disease", hypothyroidism and allergic to alendronate sodium (MSD) (WAES# 1007USA00354), LIPITOR, TRICOR, DYAZIDE, BONIVA, EVISTA, ACTONEL and simvastatin (MSD) (WAES# 1007USA00355), who on 01-APR-2010 was vaccinated with a dose of ZOSTAVAX (lot# 664628/1018Y). Concomitant therapy included PREVACID, ezetimibe (MSD) and levothyroxine Na. On 24-MAY-2010 the patient was diagnosed with idiopathic thrombocytopenic purpura. That same day platelet count was performed which was 6. The patient was referred to an hematologist. On 03-JUN-2010 a platelet count was performed which was 50,000. The patient also had a bone marrow biopsy, results not provided. It was reported that the patient was undergoing IV immunoglobulin therapy, as well as  platelet transfusions, and was recovering. The reporting nurse considered idiopathic thrombocytopenic purpura to be an other important medical event. The reporting nurse considered idiopathic thrombocytopenic purpura to be life-threatening due to low platelet count. A lot check has been requested. Additional information has been requested.
Loss of feeling from waist down, lasted 24 hours. Extreme fatigue to legs for a week.
aching legs, abd pain, diarrhea, purpura ankles & legs 23MAR98 angioedema ankles;blood workup @ clinic 26MAR98 dx of henoch-Schonlein purpura;
This spontaneous case was reported by a pharmacist and describes the occurrence of BACK PAIN (severe backpain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (severe backpain). At the time of the report, BACK PAIN (severe backpain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered BACK PAIN (severe backpain) to be possibly related.    No concomitant medication reported.  No treatment information was provided.  Patient was having severe backpain and the doctor said it's from the vaccine
No other AE; Expired dose administered to patient; This spontaneous report has been received from a registered nurse referring to a 26 year old patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.    On 07-JAN-2021, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot # S023220 with expiration date of 20-OCT-2020  (strength, dose, route, frequency and anatomical location were not provided) for prophylaxis. No adverse event reported.
Severe and unending pain in my legs and feet.  This is after almost a month after the first dose.  Also major fatigue.
Body aches started around 11pm day of the shot. I was up off and on all night due to them.  These lasted through the following day but decreased a bit over time. Sore arm at injection site started the next (saturday) morning. It is still sore today (sunday) but isn't as bad.  Low grade fever on Saturday around lunch time.  Took tylenol a couple of times during the day and fever is gone today (sunday)
DTAP at right deltoid area real swollen and warm to touch.  Area hard with measurments as below.  22.5cm width over 3/4 of arm length.
Information has been received from a registered nurse concerning a 6 month old female infant with no known allergies who on 08-JUL-2008 was vaccinated orally with a third dose of 2ml of ROTATEQ vaccine live (human-bovine). It was noted that the child was administered the vaccination and vomited immediately afterward. Medical attention was sought in the office. It was unspecified if lab studies were performed. At the time of the report, the patient recovered on the same day. It was reported that the patient was "fine afterwards." There was no product quality complaint involved. No further information is available.
Redness, swelling, pain, warmth of (L) arm at site of injection - of ZOSTAVAX.
DTap and IPV administered into R deltoid. Approximately 24 hours after administration developed large area of erythema, swelling and induration involving approximately a 15 cm area of her upper arm. No fevers. Some tenderness. Getting Benadryl only.
have been sleeping both afternoon and night; pain in arm; After the second dose also i have extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (have been sleeping both afternoon and night), PAIN IN EXTREMITY (pain in arm) and FATIGUE (After the second dose also i have extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 049C21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN for Blood pressure, METFORMIN for Diabetes, HYDROCHLOROTHIAZIDE, BUPROPION HYDROCHLORIDE (WELLBUTRIN), CLONAZEPAM (KLONOPIN), ROSUVASTATIN CALCIUM (CRESTOR) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced SOMNOLENCE (have been sleeping both afternoon and night), PAIN IN EXTREMITY (pain in arm) and FATIGUE (After the second dose also i have extreme fatigue). On 29-May-2021, PAIN IN EXTREMITY (pain in arm) had resolved. At the time of the report, SOMNOLENCE (have been sleeping both afternoon and night) and FATIGUE (After the second dose also i have extreme fatigue) outcome was unknown.            No treatment medications were provided.   Patient felt full day sleeping only got up for dinner.   This case was linked to MOD-2021-117012 (Patient Link).
Pt was given TDAP rather than DTAP in error. Parent notified. Pt brought in and given DTAP as directed.
EPILEPTIC SEIZURE; This spontaneous report received from a patient concerned a 60 year old male. The patient's height and weight were not reported. Concurrent conditions included: high blood pressure and epilepsy. The patient had no known drug allergies (NKDA). The patient had been diagnosed with epilepsy back in 2016 and has been on medications for it for the past 5 years. He states he has not had a seizure since he has been on the medication for it. The patient previously received with covid-19 vaccine ad26. cov2. s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 043A21A and expiry: unknown) dose was not reported, 1 total, administered on 10-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following primary vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received booster of covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: unknown) dose was not reported, 1 total, administered at right arm on 16-DEC-2021 for prophylactic vaccination on right arm (dose number in series 2).  The patient has high blood pressure and for which he was on two blood pressure medications.  On Saturday night of 18-DEC-2021, patient experienced an epileptic seizure (Dose number in series 2). Patient stated that, he was disoriented after the seizure but was fine afterwards and he could hear his wife after the seizure. The patient went to work Monday and Tuesday before hearing back from physician. He took Keppra (levetiracetam) 1000mg twice a day and before that he was on 750mg of Keppra twice a day. The patient stated that, due to seizure and his work he cannot be on the road for at least 3 months.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from epileptic seizure.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220107552- Covid-19 vaccine ad26.cov2.s-epileptic seizure. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event
Hives all over body except face,  extreme itchiness. Started off just around stomach then spread to all over by next day.  Took Prednisone  50mg for 5 days and Zrytec and Benedryl . Used hydrocortisone cream as well as needed throughout day.  Hives and itchiness lasted until 12/27/21 but still have red marks that flare up after taking a warm or hot shower.
chills; icy hot feeling all over body; muscle spasms; twitching; numb/tingly sensations; numb/tingly sensations; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Aug2021 at 19:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Aug2021 at 00:00, the patient experienced chills, icy hot feeling all over body, muscle spasms, twitching and numb/tingly sensations. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with dexamethasone and antibiotics. On 03Sep2021, the patient underwent PCR (Nasal swab) and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events chills, icy hot feeling all over body, muscle spasms, twitching and numb/tingly sensations was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
PATIENT CALLED PHARMACY ON 10/3 WITH COMPLAINT OF THROBING PAIN RADIATING DOWN HER ELBOW, VIBRATION DOWN THE BODY  WEAKNESS AND ON 10/2 SHE REPORTED VISITING EMERGENCY BUT NOT BEING ADDMITTED AND NO DIAGNOSIS OR PAIN ORIGIN DISCOVERED.
I took the shot yesterday morning at 10:30 a.m.  At mid-morning, my chest began to feel very congested. I began to run fever. My left arm, where I was injected, began to hurt. Through the day my symptoms began to deteriorate. I began to hurt all over my body especially my left arm and surrounding areas. My throat is sore, coughing and sneezing. ONE INCH BELOW THE INJECTION IS A HORRIBLE RED PRICKLY RASH! IT IS VERY SWOLLEN AND VERY HOT!  I will be contacting my doctor tomorrow!  I have only taken the flu shot once before.  I became sick but nothing like this.  WAS THIS A BAD BATCH OF VACCINE?
pt recv vax 7APR(7 & pt devel a fever on the way home from MD office;the fever has been coming & going for the past 7 days;pt was treated w/APAP, Rocephin & amoxicillin (for red ear seen on office exam 11APR97);
Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and NAUSEA (Nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citerate free, Solution for injection in pre-filled pen. On 04-Apr-2021, the patient experienced CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, CHILLS (Chills) and NAUSEA (Nausea) was resolving.            The concomitant medication was not reported by reporter. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The treatment medication was not reported by reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient complains of arm pain...mostly at night. This has not resolved itself. She also complained of muscle and joint pain and loss of strength and energy for 3 and 1/2 weeks after the vaccination. That has resolved itself, but the arm pain has not.
Patient developed a red rash on her neck and upper chest within 24 hours of vaccination.  It was still there after 6 days.  Patient did not experience this after the other COVID vaccines.
Pt had first pfizer covid 19 vaxx on 1/19/22. Pt was administered second vaxx and given pfizer bivalent rather than completing primary series.
At 11:28 12/9/2006, donor received tetanus toxoid 0.5ml in right arm. Tetanus was administered previously to donor with side effects about 10 year ago. Donor felt "light headed." Pulse 76, BP 116/64. Monitored donor. Donor "felt better" and left center.
Softball sized swelling at vaccine site, left arm Fever of 103.2° at 1530 on 9/16/21, lasting until 0230 9/17/21 Nausea/vomiting
Small firm area of discoloration on right and left lateral thigh. (2/21/16). 1 cm firm subcutaneous nodule lateral thighs w/o tenderness (+) mild bruising (2/22/16).
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Chills-Medium, Systemic: Hypertension-Mild, Systemic: Tachycardia-Mild, Additional Details: Nurse Practitioner and administering pharmacist oversaw patient's adverse reaction. Patient flagged Rph noting chest and throat tightness with difficulty breathing. Nurse Practitioner called 911/EMS per protocol. Patient was still able to breath with moderate difficulty from baseline. No redness/rash observed. NP offered epinephrine - patient declined. Rph offered Benadryl - patient accepted and ingested 100mg diphenhydramine po. EMS arrived within 10min and took pt to ER. current status unknown
rash is slightly tingly; red rash from the injection site; headache; chills and sweats; tired; sweaty; thirsty; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Jun-2021 and was forwarded to Moderna on 01-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweaty), THIRST (thirsty), PARAESTHESIA (rash is slightly tingly), VACCINATION SITE RASH (red rash from the injection site) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 069C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medication history was provided.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 29-May-2021, the patient experienced HYPERHIDROSIS (sweaty), THIRST (thirsty), HEADACHE (headache), CHILLS (chills and sweats) and FATIGUE (tired). On 31-May-2021, the patient experienced PARAESTHESIA (rash is slightly tingly) and VACCINATION SITE RASH (red rash from the injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form and TRIAMCINOLONE ACETONIDE ACETATE ongoing since an unknown date for Rash, at a dose of UNK dosage form. At the time of the report, HYPERHIDROSIS (sweaty), THIRST (thirsty), PARAESTHESIA (rash is slightly tingly), VACCINATION SITE RASH (red rash from the injection site), HEADACHE (headache), CHILLS (chills and sweats) and FATIGUE (tired) outcome was unknown.            Treatment medication was not provided  Action taken with mRNA-1273 in response to the event was not applicable   Reporter did not allow further contact
This spontaneous report as received from a pharmacist refers to a currently 4.5 months old male patient. The patient had no pertinent medical history nor drug reactions or allergies. Approximately on 25-JUL-2013 at the patient's "2 months old appointment the patient received his first 0.5 ml dose of ROTATEQ" with no adverse effects. On 22-AUG-2013 the patient was vaccinated with ROTATEQ (dose 2, 0.5 ml, oral; lot number not reported). No concomitant medication was reported. She reports that after the second dose of ROTATEQ, approximately at 3 months of age the patient was admitted to the hospital and was diagnosed with intussusception after an ultrasound (onset date reported as 09-SEP-2013). The intussusception was reduced by air enema (approximately in September 2013). The patient sought medical attention. The patient was reported as recovered in 2013. Additional information has been requested.